Scientists have found that people who live past 110 carry unusually large numbers of a rare immune cell built to hunt down and destroy dangerous cells before they turn into cancer.
Quick Take
- Supercentenarians show a marked rise in cytotoxic CD4 T cells, a rare immune cell type that researchers call a hallmark of extreme longevity.
- A 2019 study found these cells multiplied through massive cloning, meaning the body copied a few winning cell lines over and over.
- A newer 2026 study reports levels of these killer cells running more than four times higher than in younger seniors.
- Scientists think the cells may help clear cancerous or worn-out cells, supporting both longer life and better health.
What Researchers Found In The Blood Of The Oldest People Alive
Scientists from the RIKEN Center for Integrative Medical Science and Keio University School of Medicine in Japan studied blood from people who reached 110 years old, known as supercentenarians. Using single-cell technology that reads the activity of individual immune cells, they found something strange. These extremely old but healthy people carried far more cytotoxic CD4 T cells than younger adults do, a cell type researchers now call a signature of supercentenarians.
Most CD4 T cells work as helpers. They send signals that direct other immune cells into battle instead of fighting directly. Cytotoxic CD4 T cells behave differently. They act like the immune system’s hired killers, carrying the tools to directly destroy abnormal or infected cells, a job normally reserved for a different cell type called CD8 T cells.
How A 2019 Discovery Became A Bigger Pattern
The original 2019 research went further than just counting cells. Scientists sequenced the T cell receptors, the molecular tags that show which cells came from which original ancestor, in two supercentenarians. They found the killer CD4 cells had multiplied through massive clonal expansion, meaning a small number of original cells copied themselves again and again.
That pattern suggested the immune system kept reusing its most successful fighters instead of constantly building new ones. Later reviews describe this buildup as reaching striking levels, with cytotoxic CD4 cells making up as much as one quarter of all CD4 T cells in some supercentenarians, compared to a small fraction in younger people.
Why These Killer Cells May Matter For Cancer And Aging
A follow-up study published in Cell Reports in 2026 built on the original findings using a larger group of subjects. Researchers reported that the proportion of these killer cells climbs steadily with age and can run more than four times higher in supercentenarians than in younger elderly people, according to reporting on the study.
The newer research also found the cells start expanding noticeably around age 100, not just at the extreme end of life past 110. That timing matters because it suggests the immune shift begins well before someone reaches supercentenarian status, building gradually over the final decades of a long life.
Separate lab work outside the supercentenarian studies has shown that cytotoxic CD4 T cells can clear out senescent cells, the damaged, aging cells that build up in tissue and drive inflammation and disease over time. That connection gives researchers a plausible reason why more of these killer cells might track with unusually long, healthy lives.
What Scientists Still Want To Learn
Researchers studying centenarians describe this killer-cell buildup as one piece of a larger immune makeover seen in the oldest-old, alongside changes in other T cell types and better control of inflammation. Reviews frame it as part of a broader resilience pattern rather than a single magic cell type responsible for extreme age.
Scientists caution that cytotoxic CD4 T cells can play both protective and harmful roles depending on the context, since the same cell type shows up in some disease states as well. That nuance is why researchers keep studying exactly how these cells behave differently in people who live exceptionally long, healthy lives.
For readers past 40 watching their own aging bodies, the takeaway is straightforward. The people who last the longest are not simply lucky. Their immune systems appear to build and multiply a specialized defense force, and understanding how that happens could eventually shape how doctors help the rest of us age better.
Sources:
sciencedaily.com, pnas.org, riken.jp, pubmed.ncbi.nlm.nih.gov, frontiersin.org, scientificamerican.com, biorxiv.org
